• Join
  • Login
  • Contact
Press Releases 

Latest FIP resource on management of colds, influenza and sinusitis aims to support pharmacists and health systems

All press releases

The Hague • 14 December 2021

A new handbook, published today by the International Pharmaceutical Federation (FIP) in collaboration with The Clean Breathing Institute, aims to strengthen pharmacists’ essential roles in supporting the appropriate management of common upper respiratory tract infections (URTIs).

These roles are varied and have been defined in the handbook as: supporting self-care (e.g., advice on the use of non-prescription medicines); preventing infection and supporting respiratory well-being (e.g., through use of facemasks, nasal hygiene and good ventilation of indoor spaces); assessing symptoms; referring patients when needed; patient education and counselling (e.g., on antimicrobial resistance and how to administer nasal formulations); providing care via minor ailment schemes; and giving evidence-based advice on complementary medicines.

“URTIs are frequent reasons for which patients seek healthcare advice, with an estimated 17.2 billion cases in 2019. As demands for health care increase, we need a new approach that empowers people to manage their own health and well-being, helping to relieve pressure on overburdened healthcare systems. This new resource from FIP supports pharmacists in providing primary health care for URTIs, and in their responsibility to support informed self-care,” said Mr Paul Sinclair, chair, FIP Board of Pharmaceutical Practice.

The handbook contains guidance on managing the common cold, influenza and sinusitis. It also highlights evidence that exposure to air pollutants interferes with processes essential to the immune response, increasing susceptibility to developing respiratory infections. “Air pollution represents important challenges for health and primary health care, and in recent years FIP has been encouraging pharmacists to help mitigate the impact of air pollution on respiratory well-being,” Mr Sinclair said.

He added: “The adoption of preventive measures by populations all around the world during the COVID-19 pandemic has had an impact on the transmission rates not only of SARS-CoV2, but also of infectious respiratory diseases in general. However, URTIs and inflammation are and will probably remain among the most common reasons for consultations with community pharmacists.”
Production of the handbook was supported by unrestricted funds from The Clean Breathing Institute, a scientific initiative funded by GSK Consumer Healthcare.

“COVID-19 has brought about deeper research into how respiratory infections are transmitted and the best ways to mitigate symptoms when managing a URTI. We want to bring all of that new knowledge to community pharmacists, so they can better help patients manage the symptoms of cold, flu and sinusitis via self-care approaches,” said Ms Tess Player, global head of expert and influence marketing at GSK Consumer Healthcare.

Ms Player added: “Community pharmacists have always been at the heart of self-care, and they will continue to play a vital role in the future of healthcare systems worldwide. This is why we have made a long-term commitment to support pharmacy teams with valuable content that can help them in their daily practice, like this timely and informative handbook.”

Notes for editors

Links “Cold, flu and sinusitis: Managing symptoms and supporting self-care — A handbook for pharmacists” is available here.

About FIP The International Pharmaceutical Federation (FIP) is the global federation of national associations of pharmacists and pharmaceutical scientists, and is in official relations with the World Health Organization. Through our 147 member organisations, we represent over four million practitioners and scientists around the world. Our vision is a world where everyone benefits from access to safe, effective, quality and affordable medicines and pharmaceutical care.

About The Clean Breathing Institute The Clean Breathing Institute partners scientific expertise of academic, institutional and international bodies, plus medical professionals and innovators from science, technology, engineering, mathematics (STEM) and commercial backgrounds. The institute has been established with the aim of creating a network that works together to help reduce the effects of air pollution on respiratory health and quality of life, prioritising clean breathing.

Lin-Nam Wang
Head of Corporate Communications & Advocacy
Tel +31 70 302 1979

Last update 5 July 2018

FIP Congresses